Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call
June 02 2016 - 3:05AM
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW),
today announced that the financial results for its fiscal year and
fourth quarter 2016, ended March 31, 2016, will be released after
the U.S. markets close on June 16, 2016. The earnings release will
be followed by a conference call at 1:30 p.m. PDT on June 16, 2016,
to discuss fiscal fourth quarter and year end results.
Individuals interested in participating in the conference call
may do so by dialing 877-303-7607 for domestic callers or
973-638-3203 for international callers. Those interested in
listening to the conference call live via the internet may do so at
http://ir.oculusis.com/events.cfm. Please log on
approximately 30 minutes prior to the presentation in order to
register and download the appropriate software.
A telephone replay will be available for seven days following
the conclusion of the call by dialing 855-859-2056 for domestic
callers, or 404-537-3406 for international callers, and entering
conference code 11222664. A webcast replay will be available on the
site at http://ir.oculusis.com/events.cfm for one year following
the call.
About Oculus Innovative Sciences, Inc.Oculus
Innovative Sciences is a specialty pharmaceutical company that
develops and markets solutions for the treatment of
dermatological conditions and advanced tissue care. The company’s
products, which are sold throughout the United States and
internationally, have improved outcomes for more than five million
patients globally by reducing infections, itch, pain, scarring
and harmful inflammatory responses. The company's headquarters are
in Petaluma, California, with manufacturing operations in the
United States and Latin America. European marketing and sales
are headquartered in Roermond, Netherlands. More information can be
found at www.oculusis.com.
Media and Investor Contact:
Oculus Innovative Sciences, Inc.
Dan McFadden
VP of Public and Investor Relations
(425) 753-2105
dmcfadden@oculusis.com
Sonoma Pharmaceuticals (NASDAQ:SNOAW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sonoma Pharmaceuticals (NASDAQ:SNOAW)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sonoma Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles